Research

Hormonal

Semaglutide use is associated with acute kidney injury (AKI), specifically acute interstitial nephritis (AIN) and podocytopathies (FSGS/MCD), particularly in patients with pre-existing chronic kidney disease (CKD) or advanced age.

If you are taking semaglutide and notice swelling, changes in urination, or fatigue, report it to your doctor immediately, especially if you have existing kidney disease. Most cases of kidney injury from semaglutide are reversible if the drug is stopped early and treated with steroids.

ModerateSupportsMEDIUM confidence
We report two cases of semaglutide-associated biopsy-proven AIN and one with associated podocytopathy... Both patients experienced complete remission shortly after discontinuing semaglutide and undergoing immunosuppressive therapy.
Farhana Begum et al. · Clinical Kidney Journal · 2024

Why this rating

Based on case reports and FAERS database analysis, which lacks causality confirmation and incidence rates, but includes biopsy-proven cases.

Source

Semaglutide-associated kidney injury

Farhana Begum et al. · Clinical Kidney Journal · 2024

DOI 10.1093/ckj/sfae250

case_series · n=2Cited 19×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →